Clinical data | |
---|---|
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.697 |
Chemical and physical data | |
Formula | C36H42Br2N2 |
Molar mass | 662.554 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Hexafluronium (or hexafluorenium) is a muscle relaxant. It acts as a nicotinic acetylcholine receptor antagonist.
References
- Baraka A (August 1975). "Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase". British Journal of Anaesthesia. 47 (8): 885–8. doi:10.1093/bja/47.8.885. PMID 1201167.
Nicotinic acetylcholine receptor modulators | |||||
---|---|---|---|---|---|
nAChRsTooltip Nicotinic acetylcholine receptors |
| ||||
Precursors (and prodrugs) | |||||
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |